University of California, San Francisco

National Institute of Health, NIH

UNC Chapel Hill

Icahn School of Medicine at Mount Sinai

Recanati/Miller Transplantation Institute at Mount Sinai

Niddk, Nih, Liver Diseases Branch

Ain Shams University

Despite the development of remarkably effective direct-acting antivirals, with the ongoing opioid epidemic and continued unsafe medical practices globally, new hepatitis C virus (HCV) infections continue to outpace cures, limiting progress towards HCV eli

Join Dr. Jay Hoofnagle and Dr. Bonnie Burgess-Beusse, with the staff of the Liver Disease Research Branch of NIDDK to hear about the current status of liver disease research funding and new opportunities for research project grant and clinical research fu